Effects of Cognitive Behavioral Therapy-Based Intervention on Improving Glycaemic, Psychological, and Physiological Outcomes in Adult Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials

Xiangyun Yang, Zhanjiang Li, Jing Sun, Xiangyun Yang, Zhanjiang Li, Jing Sun

Abstract

Background: Patients with diabetes mellitus (DM) have a high risk of secondary physiological and psychological complications. Some interventions based on cognitive behavioral therapy (CBT) have been used to control glucose levels and improve negative emotions of patients with DM. This study was undertaken to provide an overview of the effectiveness of CBT-based interventions for improving glycaemic control, psychological, and physiological outcomes in adult patients with DM.

Methods: Randomized controlled trials (RCTs) published in English and Chinese during 2007 and April 2019 were searched through various electronic databases including PubMed, Cochrane Library, Scopus, Embase, ProQuest Dissertations and Theses, and the Chinese databases (WanFang data and China National Knowledge Infrastructure). The primary outcome variables included glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), depression, and anxiety symptoms. The secondary outcomes were weight and cholesterol. Effect sizes were pooled by random-effects modelling using Comprehensive Meta-Analysis software. Physiotherapy Evidence Database tool was used to assess the quality of all included studies.

Results: Twenty-three RCTs comprising 2,619 patients with DM (type 1 and type 2) were included in at least one meta-analysis. The results of the main analysis showed that CBT-based interventions had a better effect on reduced HbA1c (-0.275%, 95% CI: -0.443 to -0.107; p < 0.01) with Hedge's g of 0.466 (95% CI: 0.710 - 0.189), reduced depression symptoms with average reduction of -2.788 (95% CI: -4.450 to -1.207; p < 0.01) and Hedge's g of 0.966 (95% CI: 1.507 - 0.426). Twenty-three RCTs comprising 2,619 patients with DM (type 1 and type 2) were included in this meta-analysis. Several mediators of the effect were found through subgroup analysis for HbA1c and depression symptoms. The interventions emphasising completion homework assignments, stress management, and that used an interpersonal strategy delivered via a group had a better effect on both HbA1c and depression symptoms. In addition, behavioral strategies had a better effect on glycaemic control, and cognitive strategies had a better effect on depression symptoms. There was no difference in the change of FPG, anxiety symptoms, weight, and high-density lipoprotein cholesterol (HDL-C) between CBT-based interventions and the control conditions.

Conclusions: The findings indicate that CBT-based interventions are effective for improving glycaemic control and depression symptoms in adult patients with type 1 DM (T1DM) or type 2 DM (T2DM) with moderate to large effect size. The results of the subgroup analysis suggest that it is necessary to adopt different types and technical components of CBT according to the population and purpose of the treatment in clinical practice. Due to the high heterogeneity of included studies and other limitations, further study including large number of studies is needed to confirm these results.

Keywords: cognitive behavioral therapy; diabetes mellitus; glycaemic control; meta-analysis; mood symptoms.

Copyright © 2020 Yang, Li and Sun.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
(A) Forest plots of the effects of CBT-based intervention on HbA1c, depressive symptom, anxiety symptom, and fasting blood glucose. (B) Forest plots of the effects of CBT-based intervention on weight, total cholesterol, and high-density lipoprotein cholesterol.

References

    1. Association AD. Standards of medical care in diabetes-2013. Diabetes Care (2013) 36(Supplement 1):s11–38. 10.2337/dc13-S011
    1. Carol E, Koro SJB, Bourgeois N, Fedder DO. Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes: A preliminary report. Diabetes Care (2004) 27(1):17–20. 10.2337/diacare.27.1.17
    1. Sun J, Buys NJ. Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials. Br J Nutr (2016) 115(7):1167–77. 10.1017/S0007114516000076
    1. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabetes Med (2009) 26(2):153–61. 10.1111/j.1464-5491.2008.02648.x
    1. Chapman A, Liu S, Merkouris S, Enticott JC, Yang H, Browning CJ, et al. Psychological Interventions for the Management of Glycemic and Psychological Outcomes of Type 2 Diabetes Mellitus in China: A Systematic Review and Meta-Analyses of Randomized Controlled Trials. Front Public Health (2015) 3:252. 10.3389/fpubh.2015.00252
    1. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ (2006) 333(7558):65. 10.1136/bmj.38874.652569.55
    1. Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S, et al. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabetes Med (2020) 37(5): 735–46. 10.2139/ssrn.3414430
    1. Ridgway N, Williams C. Cognitive behavioural therapy self-help for depression: an overview. J Ment Health (2011) 20(6):593–603. 10.3109/09638237.2011.613956
    1. Tolin DF. Is cognitive–behavioral therapy more effective than other therapies?: A meta-analytic review. Clin Psychol Rev (2010) 30(6):710–20. 10.1016/j.cpr.2010.05.003
    1. Nash J. Diabetes and Wellbeing: managing the psychological and emotional challenges of diabetes Types 1 and 2. 2ed Hoboken, New Jersey, American: Wiley-Blackwell; (2013).
    1. Elliott S. Cognitive behavioural therapy and glycaemic control in diabetes mellitus. Pract Diabetes (2012) 29(2):67–71. 10.1002/pdi.1661
    1. Uchendu C, Blake H. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetes Med (2017) 34(3):328–39. 10.1111/dme.13195
    1. Wang ZD, Xia YF, Zhao Y, Chen LM. Cognitive behavioural therapy on improving the depression symptoms in patients with diabetes: a meta-analysis of randomized control trials. Biosci Rep (2017) 37(2):BSR20160557. 10.1042/BSR20160557
    1. Li C, Xu D, Hu M, Tan Y, Zhang P, Li G, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res (2017) 95:44–54. 10.1016/j.jpsychores.2017.02.006
    1. Herbert JD. Acceptance and mindfulness in cognitive behavior therapy: understanding and applying the new therapies. Hoboken, New Jersey, American: John Wiley & Sons; (2011).
    1. Kahl KG, Winter L, Schweiger U. The third wave of cognitive behavioural therapies: what is new and what is effective? Curr Opin Psychiatry (2012) 25(6):522–8. 10.1097/YCO.0b013e328358e531
    1. Gregg JA, Callaghan GM, Hayes SC, Glenn-Lawson JL. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol (2007) 75(2):336–43. 10.1037/0022-006X.75.2.336
    1. Tovote KA, Fleer J, Snippe E, Peeters ACTM, Emmelkamp PMG, Sanderman R, et al. Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: Results of a randomized controlled trial. Diabetes Care (2014) 37(9):2427–34. 10.2337/dc13-2918
    1. van Son J, Nyklíček I, Pop ,VJ, Blonk MC. The effects of a mindfulness-based intervention on emotional distress, quality of life, and HbA(1c) in outpatients with diabetes (DiaMind): a randomized controlled trial. Diabetes Care (2013) 36:823–30. 10.2337/dc12-1477
    1. Kumar V, Sattar Y, Bseiso A, Khan S, Rutkofsky IH. The Effectiveness of Internet-Based Cognitive Behavioral Therapy in Treatment of Psychiatric Disorders. Cureus (2017) 9(8):e1626. 10.7759/cureus.1626
    1. Franco P, Gallardo AM, Urtubey X. Web-based interventions for depression in individuals with diabetes: Review and discussion. J Med Internet Res (2018) 20(9):e13. 10.2196/preprints.9694
    1. Alanzi T, Alanazi NR, Istepanian R, Philip N. Evaluation of the effectiveness of mobile diabetes management system with social networking and cognitive behavioural therapy (CBT) for T2D. Mhealth (2018) 4:35. 10.21037/mhealth.2018.06.05
    1. Ismail K, Thomas SM, Maissi E, Chalder T, Schmidt U, Bartlett J, et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Internal Med (2008) 149(10):708–19. 10.7326/0003-4819-149-10-200811180-00005
    1. De Greef KP, Deforche BI, Ruige JB, Bouckaert JJ, Tudor-Locke CE, Kaufman JM, et al. The effects of a pedometer-based behavioral modification program with telephone support on physical activity and sedentary behavior in type 2 diabetes patients. Patient Educ Couns (2011) 84(2):275–9. 10.1016/j.pec.2010.07.010
    1. Mahdizadeh M, Peymam N, Taghipour A, Esmaily H, Mahdizadeh SM. Effect of health education program on promoting physical activity among diabetic women in Mashhad, Iran: applying social cognitive theory. J Res Health Sci (2013) 13(1):90–7.
    1. Whitehead LC, Crowe MT, Carter JD, Maskill VR, Carlyle D, Bugge C, et al. A nurse-led interdisciplinary approach to promote self-management of type 2 diabetes: a process evaluation of post-intervention experiences. J Eval Clin Pract (2017) 23(2):264–71. 10.1111/jep.12594
    1. van Bastelaar Kim MP, Pouwer F, Cuijpers P, Snoek Frank J. Web-based cognitive behavioural therapy for diabetes patients with comorbid depression: a randomized controlled study. Psychol gezondheid (2009) 37(4):222–8. 10.1007/BF03080404
    1. Verhagen AP, de Vet HC, de Bie RA, Kessels AGH, Boers M, Bouter LM, Knipschild PG. The Delphi List: A Criteria List for Quality Assessment of Randomized Clinical Trials for Conducting Systematic Reviews Developed by Delphi Consensus. J Clin Epidemiol (1998) 51(12):1235–41. 10.1016/S0895-4356(98)00131-0
    1. Rutger W, Trijsburg GCFJF, Gorlee M, Klouwer E, den Hollander AM, Duivenvoorden HJ. Development of the Comprehensive Psychotherapeutic Interventions Rating Scale CPIRS. Psychother Res (2002) 12(3):287–317. 10.1093/ptr/12.3.287
    1. Liu J, Gill NS, Teodorczuk A, Li ZJ, Sun J. The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials. J Affect Disord (2019) 245:98–112. 10.1016/j.jad.2018.10.114
    1. Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EH, Van Broeckhuysen-Kloth SA, et al. Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry (2014) 204(1):12–9. 10.1192/bjp.bp.112.121830
    1. Amsberg S, Anderbro T, Wredling R, Lisspers J, Lins PE, Adamson U, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients–a randomized controlled trial. Patient Educ Couns (2009) 77(1):72–80. 10.1016/j.pec.2009.01.015
    1. De Greef K, Deforche B, Tudor-Locke C, De Bourdeaudhuij I. A cognitive-behavioural pedometer-based group intervention on physical activity and sedentary behaviour in individuals with type 2 diabetes. Health Educ Res (2010) 25(5):724–36. 10.1093/her/cyq017
    1. Guan Xiaobo LZ, Zhen G, Tao L, Xueli S, Chengge G, Dong G. Effect of group cognitive behavioral therapy on blood glucose leves, anxiety and depression in patients with type 2 diabetes mellitus. Chin J Gen Pract (2015) 14(3):206–11.
    1. Huang CY, Lai HL, Chen CI, Lu YC, Li SC, Wang LW, et al. Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial. Qual Life Res (2016) 25(5):1275–83. 10.1007/s11136-015-1165-6
    1. Inouye J, Li D, Davis J, Arakaki R. Psychosocial and Clinical Outcomes of a Cognitive Behavioral Therapy for Asians and Pacific Islanders with Type 2 Diabetes: A Randomized Clinical Trial. Hawaii J Med Public Health (2015) 74(11):360–8.
    1. Li Xiaojing ZL, Qin L, Yerong Y, Xu L, Xueli S. Effects of group cognitive behavior therapy in patients with type 2 diabetes mellitus. J Psychiatry (2018) 31(3):177–80.
    1. Menting J, Tack CJ, van Bon AC, Jansen HJ, van den Bergh JP, Mol MJTM, et al. Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. Lancet Diabetes Endocrinol (2017) 5(6):448–56. 10.1016/S2213-8587(17)30098-0
    1. Penckofer SM, Ferrans C, Mumby P, Byrn M, Emanuele MA, Harrison PR, et al. A psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann Behav Med (2012) 44(2):192–206. 10.1007/s12160-012-9377-2
    1. Petrak F, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: The Diabetes and Depression (DAD) Study: A randomized controlled multicenter trial. Diabetes Care (2015) 38(5):767–75. 10.2337/dc14-1599
    1. Piette JD, Richardson C, Himle J, Duffy S, Torres T, Vogel M, et al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care (2011) 49(7):641–8. 10.1097/MLR.0b013e318215d0c9
    1. Ridge K, Bartlett J, Cheah Y, Thomas S, Lawrence-Smith G, Winkley K, et al. Do the effects of psychological treatments on improving glycemic control in type 1 diabetes persist over time? A long-term follow-up of a randomized controlled trial. Psychosom Med (2012) 74(3):319–23. 10.1097/PSY.0b013e31824c181b
    1. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care (2014) 37(3):625–33. 10.2337/dc13-0816
    1. Sharif F, Masoudi M, Ghanizadeh A, Dabbaghmanesh MH, Ghaem H, Masoumi S. The effect of cognitive-behavioral group therapy on depressive symptoms in people with type 2 diabetes: A randomized controlled clinical trial. Iran J Nurs Midwifery Res (2014) 19(5):529–36.
    1. Shayeghian Z, Hassanabadi H, Aguilar-Vafaie ME, Amiri P, Besharat MA. A Randomized Controlled Trial of Acceptance and Commitment Therapy for Type 2 Diabetes Management: The Moderating Role of Coping Styles. PloS One (2016) 11(12):e0166599. 10.1371/journal.pone.0166599
    1. Snoek FJ, van der Ven NC, Twisk JW, Hogenelst MH, Tromp-Wever AM, van der Ploeg HM, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabetes Med (2008) 25(11):1337–42. 10.1111/j.1464-5491.2008.02595.x
    1. Sun Yan LZ. Li Guiliang Influence study of group-based cognitive behavioral therapy in glycometabolism and common negative emotions of anxiety and depression for T2DM patients. Chin J Pract Nervous Dis (2015) 18(23):15–7.
    1. van Son J, Nyklíček I, Pop VJ, Blonk MC, Erdtsieck RJ, Pouwer F. Mindfulness-based cognitive therapy for people with diabetes and emotional problems: Long-term follow-up findings from the DiaMind randomized controlled trial. J Psychosom Res (2014) 77(1):81–4. 10.1016/j.jpsychores.2014.03.013
    1. Weinger K, Beverly EA, Lee Y, Sitnokov L, Ganda OP, Caballero AE. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. Arch Intern Med (2011) 171(22):1990–9. 10.1001/archinternmed.2011.502
    1. Welschen LM, van Oppen P, Bot SD, Kostense PJ, Dekker JM, Nijpels G. Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial. J Behav Med (2013) 36(6):556–66. 10.1007/s10865-012-9451-z
    1. Wroe AL, Rennie EW, Sollesse S, Chapman J, Hassy A. Is Cognitive Behavioural Therapy focusing on Depression and Anxiety Effective for People with Long-Term Physical Health Conditions? A Controlled Trial in the Context of Type 2 Diabetes Mellitus. Behav Cognit Psychother (2018) 46(2):129–47. 10.1017/S1352465817000492
    1. Fernandez E, Salem D, Swift JK, Ramtahal N. Meta-analysis of dropout from cognitive behavioral therapy: Magnitude, timing, and moderators. J Consult Clin Psychol (2015) 83(6):1108–22. 10.1037/ccp0000044
    1. Al-Haj Mohd MM, Phung H, Sun J, Morisky DE. The predictors to medication adherence among adults with diabetes in the United Arab Emirates. J Diabetes Metab Disord (2015) 15:30. 10.1186/s40200-016-0254-6
    1. Al-Haj Mohd MMM, Phung H, Sun J, Morisky DE. Improving adherence to medication in adults with diabetes in the United Arab Emirates. BMC Public Health (2016) 16(1):857. 10.1186/s12889-016-3492-0
    1. Söchting I, ProQuest E. Cognitive behavioral group therapy: challenges and opportunities. Malden, MA; Chichester, West Sussex: Wiley Blackwell; (2014).
    1. Hu DY, Pan CY, Yu JM, China Heart Survey G. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J (2006) 27(21):2573–9. 10.1093/eurheartj/ehl207
    1. Carlson M. Ebscohost. CBT for chronic pain and psychological well-being: a skills training manual integrating DBT, ACT, behavioral activation and motivational interviewing. 1 ed Malden, MA; Chichester, West Sussex: Wiley Blackwell; (2014).
    1. Wang Y-Y, Wang C-X, Wang S-B, Zhang Q-E, Wu S-L, Ng CH, et al. Cognitive behavioral therapy for post-stroke depression: A meta-analysis. J Affect Disord (2018) 235:589–96. 10.1016/j.jad.2018.04.011
    1. Hofmann SG, Wu JQ, Boettcher H. Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysis. J Consult Clin Psychol (2014) 82(3):375–91. 10.1037/a0035491
    1. American Diabetes A. Obesity Management for the Treatment of Type 2 Diabetes. Diabetes Care (2016) 39 Suppl 1:S47–51. 10.2337/dc16-S009

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere